Synonym
                                        BAY-2416964; BAY 2416964; BAY2416964; ilantimodum; ilantimod 
                                     
                                    
                                        IUPAC/Chemical Name
                                        (S)-6-(4-chlorophenyl)-N-(1-hydroxypropan-2-yl)-2-(1-methyl-1H-pyrazol-4-yl)-3-oxo-2,3-dihydropyridazine-4-carboxamide
                                     
                                    
                                        InChi Key
                                        YAGSZKAJPHGVOV-NSHDSACASA-N
                                     
                                    
                                        InChi Code
                                        InChI=1S/C18H18ClN5O3/c1-11(10-25)21-17(26)15-7-16(12-3-5-13(19)6-4-12)22-24(18(15)27)14-8-20-23(2)9-14/h3-9,11,25H,10H2,1-2H3,(H,21,26)/t11-/m0/s1
                                     
                                    
                                        SMILES Code
                                        O=C(C1=CC(C2=CC=C(Cl)C=C2)=NN(C3=CN(C)N=C3)C1=O)N[C@@H](C)CO
                                     
                                    
                                    
                                        Purity
                                        >98% (or refer to the Certificate of Analysis)
                                     
                                    
                                        Shipping Condition
                                        Shipped under ambient temperature as non-hazardous chemical.  This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
                                     
                                    
                                        Storage Condition
                                        Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
                                     
                                    
                                        Solubility
                                        Soluble in DMSO
                                     
                                    
                                        Shelf Life
                                        >3 years if stored properly
                                     
                                    
                                        Drug Formulation
                                        This drug may be formulated in DMSO
                                     
                                    
                                        Stock Solution Storage
                                        0 - 4 C for short term (days to weeks), or -20 C for long term (months).
                                     
                                    
                                        HS Tariff Code
                                        2934.99.9001
                                     
                                    
                                        More Info
                                        
                                            
                                                AhR, a member of the basic helix-loop-helix/Per-Arnt-Sim (bHLH/PAS) family of transcription factors, has important roles in regulating immunity and cellular differentiation. AhR can exhibit both pro-oncogenic and tumor suppressor-like functions depending on the tumor type; therefore, its expression may serve as a negative or positive prognostic factor
                                            
                                         
                                     
                                 
                             
                            
                                                            
                                    
                                        
                                            Biological target:
                                            
                                                
                                                    BAY 2416964 is a potent and orally active aryl hydrocarbon receptor (AHR) antagonist extracted from patent WO2018146010A1, example 192, has an IC50 of 341 nM.
                                                
                                             
                                         
                                        
                                        
                                     
                                 
                                                        
                                                                    
                                        
                                            
                                                
                                                     | 
                                                    Solvent | 
                                                    mg/mL | 
                                                    mM | 
                                                    comments | 
                                                
                                            
                                            
                                            
                                                | Solubility | 
                                            
                                                                                            
                                                    | DMSO | 
                                                    64.0 | 
                                                    165.02 | 
                                                     | 
                                                
                                                                                        
                                        
                                        
                                            Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.
                                        
                                     
                                                                
                                    Preparing Stock Solutions
                                    
                                        The following data is based on the
                                        product
                                        molecular weight
                                        387.82
                                        Batch specific molecular weights may vary
                                        from batch to batch
                                        due to the degree of hydration, which will
                                        affect the solvent
                                        volumes required to prepare stock solutions.
                                    
                                    
                                    
                                        
                                            
                                            
                                                | Concentration / Solvent Volume / Mass | 
                                                1 mg | 
                                                5 mg | 
                                                10 mg | 
                                            
                                            
                                            
                                            
                                                | 1 mM | 
                                                1.15 mL | 
                                                5.76 mL | 
                                                11.51 mL | 
                                            
                                            
                                                | 5 mM | 
                                                0.23 mL | 
                                                1.15 mL | 
                                                2.3 mL | 
                                            
                                            
                                                | 10 mM | 
                                                0.12 mL | 
                                                0.58 mL | 
                                                1.15 mL | 
                                            
                                            
                                                | 50 mM | 
                                                0.02 mL | 
                                                0.12 mL | 
                                                0.23 mL | 
                                            
                                            
                                        
                                     
                                 
                                                             
                                                            
                            
                            
                                
                                    1: Kober C, Roewe J, Schmees N, Roese L, Roehn U, Bader B, Stoeckigt D, Prinz F,
Gorjánácz M, Roider HG, Olesch C, Leder G, Irlbacher H, Lesche R, Lefranc J,
Oezcan-Wahlbrink M, Batra AS, Elmadany N, Carretero R, Sahm K, Oezen I, Cichon
F, Baumann D, Sadik A, Opitz CA, Weinmann H, Hartung IV, Kreft B, Offringa R,
Platten M, Gutcher I. Targeting the aryl hydrocarbon receptor (AhR) with BAY
2416964: a selective small molecule inhibitor for cancer immunotherapy. J
Immunother Cancer. 2023 Nov;11(11):e007495. doi: 10.1136/jitc-2023-007495. PMID:
37963637; PMCID: PMC10649913.
2: Dexheimer TS, Coussens NP, Silvers T, Jones EM, Chen L, Fang J, Morris J,
Moscow JA, Doroshow JH, Teicher BA. Combination screen in multi-cell type tumor
spheroids reveals interaction between aryl hydrocarbon receptor antagonists and
E1 ubiquitin-activating enzyme inhibitor. SLAS Discov. 2024 Oct;29(7):100186.
doi: 10.1016/j.slasd.2024.100186. Epub 2024 Oct 1. PMID: 39362362; PMCID:
PMC11562894.